Prescription RequiredOral azacitidine is a chemotherapy medicine used as continued treatment for certain adults with acute myeloid leukaemia who achieved remission after intensive chemotherapy. It helps maintain remission and delay recurrence when further intensive curative treatment cannot be completed.
| Generic Name | Azacitidine |
| Strength | 300 mg |
| Manufacturer | Hetero |
| Packing | 14 Tablets |
| Prescribed For | Blood cancer and treatment of myelodysplastic syndrome |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries. |
| Package | USD | GBP | AUD | NZD | PHP | KRW | RON | HKD | MYR | THB | AED |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 14 Tablets | $250 | £186 | A$351 | NZ$436 | ₱15,653 | ₩337,375 | lei 1,139 | HK$1,960 | RM1,018 | ฿8,168 | د.إ918 |
Azacitidine becomes incorporated into the RNA and DNA of abnormal blood cells. It changes gene activity and interferes with the production of new genetic material. These effects can restore more normal cell behaviour and reduce the growth of leukaemia cells.
Azacitidine prices may vary between countries depending on the brand, strength, pack size, pharmacy, insurance coverage, government subsidies, taxes and local healthcare policies. The following resources provide country-specific pricing, reimbursement, regulatory or medicine information.
Disclaimer
This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.
